title: Recombinant human antithrombin expressed in the milk of non-transgenic goats exhibits high efficiency on rat DIC model.
abstract: Plasma-derived antithrombin (pAT) is often used for the treatments of disseminated intravascular coagulation (DIC) patients. In this paper, the recombinant adenovirus vector encoding human antithrombin (AT) cDNA was constructed and directly infused into the mammary gland of two goats. The recombinant human antithrombin (rhAT) was purified by heparin affinity chromatography from the goat milk, and then used in the treatment of thirty lipopolysaccharide (LPS) induced DIC rats. A high expression level of rhAT up to 2.8 g/l was obtained in the milk of goats. After purification, the recovery rate and the purity of the rhAT were up to 54.7 +/- 3.2% and 96.2 +/- 2.7%, respectively. In blood of the DIC rat model treated with rhAT, the levels of antithrombin and thrombin-antithrombin (TAT) were augmented significantly; meanwhile the consumption of fibrinogen and platelet was reduced significantly, and the increase of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) concentration was restrained modest and non-significant. For the above DIC indexes, there were no differences between pAT and rhAT (P > 0.05). Our results demonstrated that the way we established is a pragmatic tool for large-scale production of rhAT, and the rhAT produced with this method has potential as a substitute for pAT in the therapy of DIC patients.
authors.affiliation: College of Animal Science, Northwest A&F University, Yangling, 712100, Shaanxi Province, People's Republic of China.
authors.forename: Hai
authors.initials: H
authors.lastname: Yang
authors.forename: Qing-Wang
authors.initials: QW
authors.lastname: Li
authors.forename: Zeng-Sheng
authors.initials: ZS
authors.lastname: Han
authors.forename: Jian-Hong
authors.initials: JH
authors.lastname: Hu
authors.forename: Wen-Ye
authors.initials: WY
authors.lastname: Li
authors.forename: Zhi-Bin
authors.initials: ZB
authors.lastname: Liu
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D000991:Antithrombins / Q000096:biosynthesis*; D002460:Cell Line; D004195:Disease Models, Animal; D004211:Disseminated Intravascular Coagulation / Q000378:metabolism* / Q000628:therapy; D005260:Female; D005786:Gene Expression Regulation; D006041:Goats; D006801:Humans; D008297:Male; D008892:Milk / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000494:pharmacology
chemical_list: D000991:Antithrombins; D011994:Recombinant Proteins